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PRELIMINARY AND SHORT REPORTS
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Pyridoxine deprivation in rats (1) and monkeys (2) causes dermatitis which resembles
fatty acid deficiency acrodynia in these animals (3) and human seborrheic dermatitis (4),
but administration of pyridoxine to persons with this condition has generally been of little
therapeutic value (5). A deficiency of pyridoxine has not been induced in human beings by
dietary limitations, but when such limitations are coupled with the administration of a
pyridoxine antagonist, desoxypyridoxine, a pyridoxine deficiency state can be induced
(6). Persons on such a regime develop seborrheic like dermatitis in the scalp and eyebrows,
in the nasolabial folds, behind the ears, over the shoulders, between the scapulae and oc-
casionally in the perineal region. This dermatitis clears rapidly when pyridoxine is given
orally or parenterally. When an ointment containing pyridoxine, 10 mg. per gram of water
soluble base is applied to a small area of an induced lesion, that area clears but distant
lesions are unaffected. If a large area is treated in this manner, all lesions disappear as do
other manifestations of pyridoxine deficiency. When the antagonist, desoxypyridoxine, is
applied in an ointment (100 mg. per gram) to spontaneous seborrheic dermatitis of the
sicca type, an exacerbation usually occurs in a week or ten days in the area treated. Because
of these observations (7) and because of the clinical and histologic similarity of desoxy-
pyridoxine induced seborrheic dermatitis to the spontaneous disease, the following experi-
ments were performed.
Thirty-six patients were selected with seborrheic dermatitis of the "sicca" type in-
volving at least the scalp, face and retroaural areas. We are well aware of the confusion
in the classification of seborrheic dermatitis and have limited the study to a form char-
acterized by mild erythema and dry scaling of the scalp, hair lines, eyebrows, ears, naso-
labial folds and less frequently forehead and cheeks. The majority of patients were in the
elderly age group. Eleven were given 300 mg. of pyridoxine daily for four weeks without
improvement in the skin lesions.
Six received 600 to 1000 mg. of pyridoxine parenterally per day for three weeks and a
water soluble ointment base was applied to the skin lesions. Only questionable improvement
was noted in several patients. Seven to ten days after discontinuation of the parenterally
administered pyridoxine, this vitamin was applied in the form of an ointment in concentra-
tion of 10 mg. per gram or to the scalp in a 20% alcoholic solution of the same vitamin con-
centration as the ointment. In these preliminary investigative studies, no observations
were made on the stability of the pyridoxine in the ointment base. Whenever possible, the
pyridoxine ointment was applied to one area and a symmetrically placed similar lesion was
treated with the water soluble base alone. The treated lesions cleared within 5—21 days
while control areas were unchanged or became worse.
Six patients were treated with pyridoxine ointment; their lesions cleared but recurred
again three to nine weeks after the ointment was discontinued. Treatment with pyridoxine
given parenterally, 100 mg. every four hours, for four weeks failed to induce a remission in
the skin lesions.
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Thirteen patients selected because of resistance to usual therapeutic procedures were
treated with pyridoxine ointment. Three failed to respond even though the concentration
of pyridoxine was increased to 50 mg. per gram.
Patients with the raw moist or secondarily infected fiexural type of seborrheic dermatitis
failed to respond to the ointment and sometimes were made worse by applying it. They
complained often of severe burning when the ointment was applied.
Acne vulgaris, acne rosacea and psoriasis were usually unaffected by the ointment.
SUIIMART AND CONCLUSIONS
1. Desoxypyridoxine, a pyridoxine antagonist, with or without a diet poor in vitamins
of the B complex will induce skin lesions which are similar to seborrheic dermatitis of the
sicca type.
2. These lesions clear in a few days when pyridoxine is added to the regime either by
oral or parenteral routes.
3. When pyridoxine is applied to a large area of the skin, all induced lesions, both local
and distant, disappear indicating that pyridoxine is easily absorbed by the skin.
4. When pyridoxine is applied topically to a small focal area of induced dermatitis, the
skin lesions disappear in this area. Distant lesions are unchanged. These experiments sug-
gest that pyridoxine can be converted in the skin to its metabolically active form, pyridoxal
phosphate.
5. Very large doses of pyridoxine given parenterally or orally had no therapeutic effect
on spontaneous seborrheic dermatitis of the sicca type but an ointment containing pyri-
doxine, 10 mg. per gram, induced healing of the lesions in 22 of 25 patients. These observa-
tions suggest that one type of seborrheic dermatitis is due to a metabolic defect in the skin
which increases the local requirement for pyridoxine.
6. There is no implication in this work that seborrheic dermatitis is due to a systemic
deficiency in pyridoxine. At the present time pyridoxine in an ointment should not be used
on the acute moist oozing forms of seborrheic dermatitis.
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ANNOUNCEMENT
The Pacific Dermatologic Association will hold its annual meeting at the
Palace Hotel in San Francisco August 29th to 31st, 1952. The guest speaker
will be Dr. Marcus R. Caro of Chicago. This year's program is under the chair-
manship of Dr. Nelson Paul Anderson of Los Angeles. Among the features will
be a demonstration of the Treponome Immobilization Test, reports on research
activities of the member universities, a clinical and histopathologic meeting and
a discussion of dermatologic economics.
